Abn Amro Bank N.V. Ginkgo Bioworks Holdings, Inc. Transaction History

Abn Amro Bank N.V.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 12, 2025	SELL	$5.57 - $11.25 $1.84 Million - $3.72 Million	-330,625 Closed	0 $0
Q3 2024 Aug 28, 2025	SELL	$0.22 - $9.31 $44,141 - $1.87 Million	-200,641 Closed	0 $0
Q2 2024 Aug 28, 2025	SELL	$0.28 - $1.16 $8,121 - $33,648	-29,007 Reduced 12.63%	200,641 $67.6 Million
Q1 2024 Aug 28, 2025	SELL	$1.06 - $1.67 $12,382 - $19,508	-11,682 Reduced 4.84%	229,648 $266 Million
Q4 2023 Aug 28, 2025	BUY	$1.26 - $1.79 $304,075 - $431,980	241,330 New	241,330 $410 Million
Q3 2023 Aug 28, 2025	SELL	$1.61 - $2.54 $197,825 - $312,097	-122,873 Reduced 27.09%	330,625 $599 Million
Q2 2023 Aug 28, 2025	SELL	$1.14 - $1.95 $53,691 - $91,841	-47,098 Reduced 9.41%	453,498 $843 Million
Q1 2023 Aug 28, 2025	BUY	$1.2 - $2.19 $600,715 - $1.1 Million	500,596 New	500,596 $668 Million

48M

Ticker DNA
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 1,287,779,968
Market Cap $13.2B
Description
Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. The company serves various end markets, including specialty chemicals, agric...

Get notified when there are updates to the investment portfolio of Abn Amro Bank N.V., based on Form 13F filings with the SEC.

Stay updated on Abn Amro Bank N.V. with notifications on news.